CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 43  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0661
LYS 10.0658
GLU 20.0117
LEU 30.0190
ARG 40.0292
CYS 50.0079
GLN 60.0135
CYS 70.0353
ILE 80.0568
LYS 90.0661
THR 100.0220
TYR 110.0038
SER 120.0023
LYS 130.0089
PRO 140.0115
PHE 150.0113
HIS 160.0206
PRO 170.0219
LYS 180.0243
PHE 190.0152
ILE 200.0164
LYS 210.0201
GLU 220.0123
LEU 230.0088
ARG 240.0198
VAL 250.0215
ILE 260.0255
GLU 270.0270
SER 280.0147
GLY 290.0427
PRO 300.0506
HIS 310.0266
CYS 320.0250
ALA 330.0388
ASN 340.0343
THR 350.0273
GLU 360.0211
ILE 370.0109
ILE 380.0122
VAL 390.0091
LYS 400.0120
LEU 410.0161
SER 420.0201
ASP 430.0240
GLY 440.0149
ARG 450.0095
GLU 460.0076
LEU 470.0041
CYS 480.0104
LEU 490.0045
ASP 500.0140
PRO 510.0176
LYS 520.0316
GLU 530.0234
ASN 540.0290
TRP 550.0185
VAL 560.0104
GLN 570.0097
ARG 580.0092
VAL 590.0062
VAL 600.0060
GLU 610.0161
LYS 620.0115
PHE 630.0160
LEU 640.0150
LYS 650.0109
ARG 660.0193
ALA 670.0357
GLU 680.0324
ASN 690.0387

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.